MUNDIPHARMA RESEARCH LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

First Posted Date
2012-12-03
Last Posted Date
2013-06-28
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
332
Registration Number
NCT01739387
Locations
🇬🇧

BioKinetic Europe Ltd, Belfast, United Kingdom

🇬🇧

Glasgow Clinical Research Facility, Glasgow, United Kingdom

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2012-01-18
Last Posted Date
2018-10-24
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
498
Registration Number
NCT01511367
Locations
🇭🇺

Illés és Ádám Egészségügyi Szolgáltató Bt., Kiskunhalas, Hungary

🇨🇿

Alergologie Skopkova s.r.o, Ostrava-Marianske Hory, Czechia

🇵🇱

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp.z.o.o., Tarnow, Poland

and more 1 locations

A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab.

First Posted Date
2011-02-03
Last Posted Date
2018-09-04
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
88
Registration Number
NCT01289223
Locations
🇸🇰

Dr Ludmila Demitrovicova, Bratislava, Slovakia

🇦🇺

Royal Adelaide Hospital, Adelaide, Australia

🇦🇺

Princess Alexandra Hospital, Brisbane, Queensland, Australia

Prospective Study on the Use of Transdermal Analgesic Buprenorphine Patches for Chronic Pain in the UK

Completed
Conditions
First Posted Date
2010-10-21
Last Posted Date
2014-05-15
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
750
Registration Number
NCT01225861
Locations
🇬🇧

Western Infirmary, Terrent Institute, Glasgow, United Kingdom

Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma

Phase 3
Completed
Conditions
Interventions
First Posted Date
2010-04-07
Last Posted Date
2018-10-24
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
261
Registration Number
NCT01099722
Locations
🇭🇺

Csongrád Megyei Önkormányzat Mellkasi Betegségek Szakkórháza Tüdőgondozó Intézet, Szeged, Hungary

Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-10-15
Last Posted Date
2018-10-24
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
46
Registration Number
NCT00995800
Locations
🇩🇪

KLB, Lubeck, Germany

A Study to Characterize the Pharmacokinetics and Tolerability of Buprenorphine Patches in Children With Moderate to Severe Mouth Pain

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2009-07-28
Last Posted Date
2018-10-24
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
25
Registration Number
NCT00947466
Locations
🇬🇧

Dr Howell, Liverpool, United Kingdom

Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.

First Posted Date
2008-08-27
Last Posted Date
2012-10-24
Lead Sponsor
Mundipharma Research Limited
Target Recruit Count
2
Registration Number
NCT00742495
Locations
🇫🇷

Prof Gerard Michel, Marseilles, France

🇩🇪

Charite Universitymedicine, Berlin, Germany

🇮🇹

Dr Giovanna Gioriani, Pavia, Italy

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath